1-20 of 28
Keywords: Acute ischaemic stroke
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Cerebrovasc Dis 1–7.
Published Online: 20 March 2024
...Anthony Pereira; Vafa Alakbarzade; Deborah Lowe; David Hargroves Background: Traditionally, non-contrast computed tomography (CT) alone was used in the initial assessment of acute ischaemic stroke patients mainly to exclude haemorrhage or alternative pathology. Summary: Late-window (beyond 6 h...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Cerebrovasc Dis (1997) 7 (Suppl. 2): 2–6.
Published Online: 26 May 2010
...Werner Hacke Although there is currently no generally accepted consensus on the management of acute ischaemic stroke, several organisations are working towards producing guidelines for this disease. A major step in ensuring the rapid presentation and treatment of sufferers would be to promote...
Journal Articles
Journal Articles
Cerebrovasc Dis (1997) 7 (Suppl. 2): 13–17.
Published Online: 26 May 2010
...Nils Gunnar Wahlgren There are many neuroprotectants currently under evaluation for the treatment of acute ischaemic stroke, but encouraging clinical trials have been rare. Neuroprotective drugs interfere with various stages of the ischaemic cascade leading to irreversible tissue damage...
Journal Articles
Journal Articles
Journal Articles
Cerebrovasc Dis (2010) 29 (3): 228–235.
Published Online: 18 December 2009
... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Acute ischaemic stroke Autoregulation TIA Transcranial Doppler...
Journal Articles
Cerebrovasc Dis (2009) 28 (6): 572–581.
Published Online: 16 October 2009
... of the efficacy and safety of IV-TPA for treatment of acute ischaemic stroke within 3 h in diverse clinical practice settings, after adjusting for potential observational bias. 22 05 2009 15 07 2009 16 10 2009 Table 1 Included studies: baseline demographics and prognostic variables...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Cerebrovasc Dis (2006) 22 (Suppl. 1): 10–17.
Published Online: 08 June 2006
...Ashfaq Shuaib Preclinical testing of putative neuroprotective agents for the treatment of acute ischaemic stroke is critical in assessing their therapeutic potential. Guidelines on how preclinical development of neuroprotectants should be performed were lacking until the Stroke Therapy Academic...
Journal Articles
Cerebrovasc Dis (2006) 22 (Suppl. 1): 3–9.
Published Online: 08 June 2006
... on family and carers. One of the main reasons why patients have such a poor prognosis is a lack of treatment options. Recombinant tissue plasminogen activator (rt-PA) is the only treatment currently licensed to treat selected patients with acute ischaemic stroke. However, only 1–8.5% of hospitalised...
Journal Articles